aluates Reports

$ 0.0

Automative

Global Leptospirosis Vaccine Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-0R18988

BUY CHAPTERS

Global Leptospirosis Vaccine Market Research Report 2024

Code: QYRE-Auto-0R18988

Report

November 2024

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Zoetis Inc

Merck Animal Health

Hipra

Boehringer Ingelheim

Virbac

Elanco

Durvet

Neotech

Leptospirosis Vaccine Market Size

The global Leptospirosis Vaccine market was valued at US$ 296 million in 2023 and is anticipated to reach US$ 484 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.

Leptospirosis Vaccine Market

The Leptospirosis Vaccine is a vaccine for dogs that protects against leptospirosis, a bacterial disease caused by Leptospira bacteria. This zoonotic disease can infect both animals and humans, and it is transmitted through the urine of infected animals, often contaminating water, soil, and food sources. Dogs that contract leptospirosis can suffer from liver and kidney damage, respiratory issues, and other severe symptoms. In some cases, leptospirosis can be fatal.

North American market for Leptospirosis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Leptospirosis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Leptospirosis Vaccine include Zoetis, Merck Animal Health, Hipra, Boehringer Ingelheim, Virbac, Elanco, Durvet, NeoTech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Leptospirosis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leptospirosis Vaccine.

The Leptospirosis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Leptospirosis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leptospirosis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Leptospirosis Vaccine Market Report

Report Metric	Details
Report Name	Leptospirosis Vaccine Market
Accounted market size in 2023	US$ 296 million
Forecasted market size in 2030	US$ 484 million
CAGR	6.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Inactivated Vaccines Live Attenuated Vaccines
Segment by Application	Puppies Adult Dogs
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Zoetis, Merck Animal Health, Hipra, Boehringer Ingelheim, Virbac, Elanco, Durvet, NeoTech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Leptospirosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Leptospirosis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Leptospirosis Vaccine Market growing?

Ans: The Leptospirosis Vaccine Market witnessing a CAGR of 6.7% during the forecast period 2024-2030.

What is the Leptospirosis Vaccine Market size in 2030?

Ans: The Leptospirosis Vaccine Market size in 2030 will be US$ 484 million.

Who are the main players in the Leptospirosis Vaccine Market report?

Ans: The main players in the Leptospirosis Vaccine Market are Zoetis, Merck Animal Health, Hipra, Boehringer Ingelheim, Virbac, Elanco, Durvet, NeoTech

What are the Application segmentation covered in the Leptospirosis Vaccine Market report?

Ans: The Applications covered in the Leptospirosis Vaccine Market report are Puppies, Adult Dogs

What are the Type segmentation covered in the Leptospirosis Vaccine Market report?

Ans: The Types covered in the Leptospirosis Vaccine Market report are Inactivated Vaccines, Live Attenuated Vaccines

Recommended Reports

Animal Vaccine Markets

Virus & Bacterial Vaccines

Companion & Livestock Disease

1 Leptospirosis Vaccine Market Overview

1.1 Product Definition

1.2 Leptospirosis Vaccine by Type

1.2.1 Global Leptospirosis Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Inactivated Vaccines

1.2.3 Live Attenuated Vaccines

1.3 Leptospirosis Vaccine by Application

1.3.1 Global Leptospirosis Vaccine Market Value by Application (2024-2030)

1.3.2 Puppies

1.3.3 Adult Dogs

1.4 Global Leptospirosis Vaccine Market Size Estimates and Forecasts

1.4.1 Global Leptospirosis Vaccine Revenue 2019-2030

1.4.2 Global Leptospirosis Vaccine Sales 2019-2030

1.4.3 Global Leptospirosis Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Leptospirosis Vaccine Market Competition by Manufacturers

2.1 Global Leptospirosis Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Leptospirosis Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Leptospirosis Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Leptospirosis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Leptospirosis Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Leptospirosis Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Leptospirosis Vaccine, Date of Enter into This Industry

2.8 Global Leptospirosis Vaccine Market Competitive Situation and Trends

2.8.1 Global Leptospirosis Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Leptospirosis Vaccine Players Market Share by Revenue

2.8.3 Global Leptospirosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Leptospirosis Vaccine Market Scenario by Region

3.1 Global Leptospirosis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Leptospirosis Vaccine Sales by Region: 2019-2030

3.2.1 Global Leptospirosis Vaccine Sales by Region: 2019-2024

3.2.2 Global Leptospirosis Vaccine Sales by Region: 2025-2030

3.3 Global Leptospirosis Vaccine Revenue by Region: 2019-2030

3.3.1 Global Leptospirosis Vaccine Revenue by Region: 2019-2024

3.3.2 Global Leptospirosis Vaccine Revenue by Region: 2025-2030

3.4 North America Leptospirosis Vaccine Market Facts & Figures by Country

3.4.1 North America Leptospirosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Leptospirosis Vaccine Sales by Country (2019-2030)

3.4.3 North America Leptospirosis Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Leptospirosis Vaccine Market Facts & Figures by Country

3.5.1 Europe Leptospirosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Leptospirosis Vaccine Sales by Country (2019-2030)

3.5.3 Europe Leptospirosis Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Leptospirosis Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Leptospirosis Vaccine Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Leptospirosis Vaccine Sales by Region (2019-2030)

3.6.3 Asia Pacific Leptospirosis Vaccine Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Leptospirosis Vaccine Market Facts & Figures by Country

3.7.1 Latin America Leptospirosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Leptospirosis Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Leptospirosis Vaccine Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Leptospirosis Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Leptospirosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Leptospirosis Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Leptospirosis Vaccine Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Leptospirosis Vaccine Sales by Type (2019-2030)

4.1.1 Global Leptospirosis Vaccine Sales by Type (2019-2024)

4.1.2 Global Leptospirosis Vaccine Sales by Type (2025-2030)

4.1.3 Global Leptospirosis Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Leptospirosis Vaccine Revenue by Type (2019-2030)

4.2.1 Global Leptospirosis Vaccine Revenue by Type (2019-2024)

4.2.2 Global Leptospirosis Vaccine Revenue by Type (2025-2030)

4.2.3 Global Leptospirosis Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Leptospirosis Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Leptospirosis Vaccine Sales by Application (2019-2030)

5.1.1 Global Leptospirosis Vaccine Sales by Application (2019-2024)

5.1.2 Global Leptospirosis Vaccine Sales by Application (2025-2030)

5.1.3 Global Leptospirosis Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Leptospirosis Vaccine Revenue by Application (2019-2030)

5.2.1 Global Leptospirosis Vaccine Revenue by Application (2019-2024)

5.2.2 Global Leptospirosis Vaccine Revenue by Application (2025-2030)

5.2.3 Global Leptospirosis Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Leptospirosis Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Zoetis

6.1.1 Zoetis Company Information

6.1.2 Zoetis Description and Business Overview

6.1.3 Zoetis Leptospirosis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Zoetis Leptospirosis Vaccine Product Portfolio

6.1.5 Zoetis Recent Developments/Updates

6.2 Merck Animal Health

6.2.1 Merck Animal Health Company Information

6.2.2 Merck Animal Health Description and Business Overview

6.2.3 Merck Animal Health Leptospirosis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck Animal Health Leptospirosis Vaccine Product Portfolio

6.2.5 Merck Animal Health Recent Developments/Updates

6.3 Hipra

6.3.1 Hipra Company Information

6.3.2 Hipra Description and Business Overview

6.3.3 Hipra Leptospirosis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Hipra Leptospirosis Vaccine Product Portfolio

6.3.5 Hipra Recent Developments/Updates

6.4 Boehringer Ingelheim

6.4.1 Boehringer Ingelheim Company Information

6.4.2 Boehringer Ingelheim Description and Business Overview

6.4.3 Boehringer Ingelheim Leptospirosis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Boehringer Ingelheim Leptospirosis Vaccine Product Portfolio

6.4.5 Boehringer Ingelheim Recent Developments/Updates

6.5 Virbac

6.5.1 Virbac Company Information

6.5.2 Virbac Description and Business Overview

6.5.3 Virbac Leptospirosis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Virbac Leptospirosis Vaccine Product Portfolio

6.5.5 Virbac Recent Developments/Updates

6.6 Elanco

6.6.1 Elanco Company Information

6.6.2 Elanco Description and Business Overview

6.6.3 Elanco Leptospirosis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Elanco Leptospirosis Vaccine Product Portfolio

6.6.5 Elanco Recent Developments/Updates

6.7 Durvet

6.7.1 Durvet Company Information

6.7.2 Durvet Description and Business Overview

6.7.3 Durvet Leptospirosis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Durvet Leptospirosis Vaccine Product Portfolio

6.7.5 Durvet Recent Developments/Updates

6.8 NeoTech

6.8.1 NeoTech Company Information

6.8.2 NeoTech Description and Business Overview

6.8.3 NeoTech Leptospirosis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 NeoTech Leptospirosis Vaccine Product Portfolio

6.8.5 NeoTech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Leptospirosis Vaccine Industry Chain Analysis

7.2 Leptospirosis Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Leptospirosis Vaccine Production Mode & Process

7.4 Leptospirosis Vaccine Sales and Marketing

7.4.1 Leptospirosis Vaccine Sales Channels

7.4.2 Leptospirosis Vaccine Distributors

7.5 Leptospirosis Vaccine Customers

8 Leptospirosis Vaccine Market Dynamics

8.1 Leptospirosis Vaccine Industry Trends

8.2 Leptospirosis Vaccine Market Drivers

8.3 Leptospirosis Vaccine Market Challenges

8.4 Leptospirosis Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Zoetis Inc

Merck Animal Health

Hipra

Boehringer Ingelheim

Virbac

Elanco

Durvet

Neotech

List of Tables

Table 1. Global Leptospirosis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Leptospirosis Vaccine Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Leptospirosis Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Leptospirosis Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Leptospirosis Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Leptospirosis Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Leptospirosis Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Leptospirosis Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Leptospirosis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Leptospirosis Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Leptospirosis Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Leptospirosis Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Leptospirosis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leptospirosis Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Leptospirosis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Leptospirosis Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global Leptospirosis Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Leptospirosis Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global Leptospirosis Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Leptospirosis Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Leptospirosis Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Leptospirosis Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Leptospirosis Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Leptospirosis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Leptospirosis Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America Leptospirosis Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America Leptospirosis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Leptospirosis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Leptospirosis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Leptospirosis Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Leptospirosis Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Leptospirosis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Leptospirosis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Leptospirosis Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Leptospirosis Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Leptospirosis Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Leptospirosis Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Leptospirosis Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Leptospirosis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Leptospirosis Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Leptospirosis Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Leptospirosis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Leptospirosis Vaccine Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Leptospirosis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Leptospirosis Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Leptospirosis Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Leptospirosis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Leptospirosis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Leptospirosis Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global Leptospirosis Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global Leptospirosis Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Leptospirosis Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Leptospirosis Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Leptospirosis Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Leptospirosis Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Leptospirosis Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Leptospirosis Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global Leptospirosis Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global Leptospirosis Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global Leptospirosis Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global Leptospirosis Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Leptospirosis Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Leptospirosis Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Leptospirosis Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Leptospirosis Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Leptospirosis Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Leptospirosis Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global Leptospirosis Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. Zoetis Company Information

Table 71. Zoetis Description and Business Overview

Table 72. Zoetis Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Zoetis Leptospirosis Vaccine Product

Table 74. Zoetis Recent Developments/Updates

Table 75. Merck Animal Health Company Information

Table 76. Merck Animal Health Description and Business Overview

Table 77. Merck Animal Health Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Merck Animal Health Leptospirosis Vaccine Product

Table 79. Merck Animal Health Recent Developments/Updates

Table 80. Hipra Company Information

Table 81. Hipra Description and Business Overview

Table 82. Hipra Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Hipra Leptospirosis Vaccine Product

Table 84. Hipra Recent Developments/Updates

Table 85. Boehringer Ingelheim Company Information

Table 86. Boehringer Ingelheim Description and Business Overview

Table 87. Boehringer Ingelheim Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Boehringer Ingelheim Leptospirosis Vaccine Product

Table 89. Boehringer Ingelheim Recent Developments/Updates

Table 90. Virbac Company Information

Table 91. Virbac Description and Business Overview

Table 92. Virbac Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Virbac Leptospirosis Vaccine Product

Table 94. Virbac Recent Developments/Updates

Table 95. Elanco Company Information

Table 96. Elanco Description and Business Overview

Table 97. Elanco Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Elanco Leptospirosis Vaccine Product

Table 99. Elanco Recent Developments/Updates

Table 100. Durvet Company Information

Table 101. Durvet Description and Business Overview

Table 102. Durvet Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Durvet Leptospirosis Vaccine Product

Table 104. Durvet Recent Developments/Updates

Table 105. NeoTech Company Information

Table 106. NeoTech Description and Business Overview

Table 107. NeoTech Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. NeoTech Leptospirosis Vaccine Product

Table 109. NeoTech Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Leptospirosis Vaccine Distributors List

Table 113. Leptospirosis Vaccine Customers List

Table 114. Leptospirosis Vaccine Market Trends

Table 115. Leptospirosis Vaccine Market Drivers

Table 116. Leptospirosis Vaccine Market Challenges

Table 117. Leptospirosis Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Leptospirosis Vaccine

Figure 2. Global Leptospirosis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Leptospirosis Vaccine Market Share by Type: 2023 & 2030

Figure 4. Inactivated Vaccines Product Picture

Figure 5. Live Attenuated Vaccines Product Picture

Figure 6. Global Leptospirosis Vaccine Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Leptospirosis Vaccine Market Share by Application: 2023 & 2030

Figure 8. Puppies

Figure 9. Adult Dogs

Figure 10. Global Leptospirosis Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Leptospirosis Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global Leptospirosis Vaccine Sales (2019-2030) & (K Units)

Figure 13. Global Leptospirosis Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 14. Leptospirosis Vaccine Report Years Considered

Figure 15. Leptospirosis Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global Leptospirosis Vaccine Revenue Share by Manufacturers in 2023

Figure 17. Global 5 and 10 Largest Leptospirosis Vaccine Players: Market Share by Revenue in Leptospirosis Vaccine in 2023

Figure 18. Leptospirosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. Global Leptospirosis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Leptospirosis Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America Leptospirosis Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. United States Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Leptospirosis Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe Leptospirosis Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Leptospirosis Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Leptospirosis Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Leptospirosis Vaccine Sales Market Share by Country (2019-2030)

Figure 41. Mexico Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Brazil Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Argentina Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Colombia Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East and Africa Leptospirosis Vaccine Sales Market Share by Country (2019-2030)

Figure 46. Middle East and Africa Leptospirosis Vaccine Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Leptospirosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Leptospirosis Vaccine by Type (2019-2030)

Figure 51. Global Revenue Market Share of Leptospirosis Vaccine by Type (2019-2030)

Figure 52. Global Leptospirosis Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 53. Global Sales Market Share of Leptospirosis Vaccine by Application (2019-2030)

Figure 54. Global Revenue Market Share of Leptospirosis Vaccine by Application (2019-2030)

Figure 55. Global Leptospirosis Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 56. Leptospirosis Vaccine Value Chain

Figure 57. Leptospirosis Vaccine Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pet Vaccine Market Research Report 2025

Global Veterinary Lyme Disease Vaccine Market Research Report 2024

Global Canine Vaccine Market Research Report 2024

Veterinary Vaccine Market

Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lyme Disease Vaccine Market Research Report 2025

Global Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024

Global Rabies Vaccine for Pets Market Research Report 2024

Global Canine Influenza Vaccine Market Research Report 2024

Global Bacterial Vaccines for Humans Market Research Report 2024

Global Vaccinations Solutions for Pets Market Research Report 2025

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mycoplasma Galliscepticum Vaccine Market Research Report 2024

Global Dog Vaccines Market Insights Forecast to 2030

Global Veterinary Biological Vaccines Market Research Report 2025

Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Animal Anti Rabies Vaccine Market Research Report 2024

Global Pneumococcal Vaccination Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions